Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6225510rdf:typepubmed:Citationlld:pubmed
pubmed-article:6225510lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:6225510lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6225510lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:6225510lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:6225510lifeskim:mentionsumls-concept:C2239176lld:lifeskim
pubmed-article:6225510lifeskim:mentionsumls-concept:C1518174lld:lifeskim
pubmed-article:6225510lifeskim:mentionsumls-concept:C0033374lld:lifeskim
pubmed-article:6225510lifeskim:mentionsumls-concept:C1550101lld:lifeskim
pubmed-article:6225510lifeskim:mentionsumls-concept:C1415793lld:lifeskim
pubmed-article:6225510lifeskim:mentionsumls-concept:C0031669lld:lifeskim
pubmed-article:6225510lifeskim:mentionsumls-concept:C1441547lld:lifeskim
pubmed-article:6225510lifeskim:mentionsumls-concept:C1515877lld:lifeskim
pubmed-article:6225510lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:6225510pubmed:issue3lld:pubmed
pubmed-article:6225510pubmed:dateCreated1983-11-23lld:pubmed
pubmed-article:6225510pubmed:abstractTextHarvest fluid derived from a primary hepatocellular carcinoma cell line (PLC/PRF/5) inhibited the incorporation of 3H-thymidine into PHA-activated human lymphocytes. A similar effect was observed when lymphocytes were pre-incubated with the tumour supernatant and washed prior to mitogen activation. Not only did the tumour supernatant inhibit 3H-thymidine incorporation by mitogen-activated lymphocytes, but it also inhibited production of the lymphokine leucocyte inhibitory factor (LIF). In experiments designed to establish whether a component of the tumour harvest fluid was activating a population of suppressor cells, normal mononuclear (MN) cells were treated with the PLC/PRF/5 or embryonic fibroblast supernatant for 48 h, after which they were washed and added to normal mitogen-activated lymphocyte cultures. Only cells pretreated with the PLC/PRF/5 supernatant suppressed mitogenesis. The cell responsible for the suppressor effect was a T cell, which after a further 24 h in culture liberated a suppressor factor responsible for inhibiting lymphocyte function. Although the nature of the factor/s in the PLC/PRF/5 supernatant responsible for activation of the T-suppressor cell population is unknown, it is suggested that this mechanism may be important in protecting the tumour from the immune response.lld:pubmed
pubmed-article:6225510pubmed:languageenglld:pubmed
pubmed-article:6225510pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6225510pubmed:citationSubsetIMlld:pubmed
pubmed-article:6225510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6225510pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6225510pubmed:statusMEDLINElld:pubmed
pubmed-article:6225510pubmed:issn0340-7004lld:pubmed
pubmed-article:6225510pubmed:authorpubmed-author:RabsonA RARlld:pubmed
pubmed-article:6225510pubmed:authorpubmed-author:KeongAAlld:pubmed
pubmed-article:6225510pubmed:issnTypePrintlld:pubmed
pubmed-article:6225510pubmed:volume15lld:pubmed
pubmed-article:6225510pubmed:ownerNLMlld:pubmed
pubmed-article:6225510pubmed:authorsCompleteYlld:pubmed
pubmed-article:6225510pubmed:pagination178-82lld:pubmed
pubmed-article:6225510pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:6225510pubmed:meshHeadingpubmed-meshheading:6225510-...lld:pubmed
pubmed-article:6225510pubmed:meshHeadingpubmed-meshheading:6225510-...lld:pubmed
pubmed-article:6225510pubmed:meshHeadingpubmed-meshheading:6225510-...lld:pubmed
pubmed-article:6225510pubmed:meshHeadingpubmed-meshheading:6225510-...lld:pubmed
pubmed-article:6225510pubmed:meshHeadingpubmed-meshheading:6225510-...lld:pubmed
pubmed-article:6225510pubmed:meshHeadingpubmed-meshheading:6225510-...lld:pubmed
pubmed-article:6225510pubmed:meshHeadingpubmed-meshheading:6225510-...lld:pubmed
pubmed-article:6225510pubmed:meshHeadingpubmed-meshheading:6225510-...lld:pubmed
pubmed-article:6225510pubmed:meshHeadingpubmed-meshheading:6225510-...lld:pubmed
pubmed-article:6225510pubmed:year1983lld:pubmed
pubmed-article:6225510pubmed:articleTitleSupernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) activates a population of T-suppressor cells.lld:pubmed
pubmed-article:6225510pubmed:publicationTypeJournal Articlelld:pubmed